Selective anti-proliferation of HER2-positive breast cancer cells by anthocyanins identified by high-throughput screening.

Overexpressed Human epidermal growth factor receptor 2 (HER2) drives the biology of 20% breast cancer and is a prediction of a poor prognosis for patients. HER2-targeted therapies significantly improve outcomes for HER2-positive patients. Traditional Chinese herbs/medicines have been used to treat b...

Full description

Bibliographic Details
Main Authors: Weihua Liu, Jinmei Xu, Shaoping Wu, Yilun Liu, Xiaoping Yu, Juan Chen, Xi Tang, Zhi Wang, Xiaohu Zhu, Xin Li
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3849376?pdf=render